盈健医疗中期收益约3.16亿港元同比增加约7.0%

格隆汇2025-02-26

格隆汇2月26日丨盈健医疗(01419.HK)发布公告，截至2024年12月31日止六个月，集团中期收益约为315.8百万港元，较2024财年中期增加约20.6百万港元或7.0%。公司拥有人应占溢利约为16.8百万港元，较2024财年中期减少约3.2百万港元或16.0%。撇除按公平值计入损益的金融资产的公平值变动及投资物业的公平值变动后，集团的公司拥有人应占溢利约为22.0百万港元，较2024财年...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2514837035?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-26 20:57","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2514837035","market":"hk","top_or_hot":-1,"title":"盈健医疗中期收益约3.16亿港元 同比增加约7.0%","media":"格隆汇","content":"<div>\n<p>格隆汇2月26日丨盈健医疗(01419.HK)发布公告，截至2024年12月31日止六个月，集团中期收益约为315.8百万港元，较2024财年中期增加约20.6百万港元或7.0%。公司拥有人应占溢利约为16.8百万港元，较2024财年中期减少约3.2百万港元或16.0%。撇除按公平值计入损益的金融资产的公平值变动及投资物业的公平值变动后，集团的公司拥有人应占溢利约为22.0百万港元，较2024财年...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226210144989396ab&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盈健医疗中期收益约3.16亿港元 同比增加约7.0%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盈健医疗中期收益约3.16亿港元 同比增加约7.0%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-26 20:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226210144989396ab&s=b><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇2月26日丨盈健医疗(01419.HK)发布公告，截至2024年12月31日止六个月，集团中期收益约为315.8百万港元，较2024财年中期增加约20.6百万港元或7.0%。公司拥有人应占溢利约为16.8百万港元，较2024财年中期减少约3.2百万港元或16.0%。撇除按公平值计入损益的金融资产的公平值变动及投资物业的公平值变动后，集团的公司拥有人应占溢利约为22.0百万港元，较2024财年...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226210144989396ab&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01419","symbol_name":"盈健医疗","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226210144989396ab&s=b","article_id":"2514837035","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226210144989396ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2514837035","pubTimestamp":1740574622,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇2月26日丨盈健医疗发布公告，截至2024年12月31日止六个月，集团中期收益约为315.8百万港元，较2024财年中期增加约20.6百万港元或7.0%。撇除按公平值计入损益的金融资产的公平值变动及投资物业的公平值变动后，集团的公司拥有人应占溢利约为22.0百万港元，较2024财年中期增加约2.9百万港元或15.0%。请读者仅作参考，并请自行承担全部责任。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01419":"盈健医疗","BK1219":"保健护理服务"},"translate_title":"Yingjian Medical's interim revenue was approximately HK $316 million, a year-on-year increase of approximately 7.0%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01419":1},"content_text":"格隆汇2月26日丨盈健医疗(01419.HK)发布公告，截至2024年12月31日止六个月，集团中期收益约为315.8百万港元，较2024财年中期增加约20.6百万港元或7.0%。公司拥有人应占溢利约为16.8百万港元，较2024财年中期减少约3.2百万港元或16.0%。撇除按公平值计入损益的金融资产的公平值变动及投资物业的公平值变动后，集团的公司拥有人应占溢利约为22.0百万港元，较2024财年中期增加约2.9百万港元或15.0%。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514837035","isCrawlerRequest":true}

盈健医疗中期收益约3.16亿港元 同比增加约7.0%

精彩评论

盈健医疗中期收益约3.16亿港元同比增加约7.0%